Q1 Earnings Estimate for Cresco Labs Issued By Roth Capital

Cresco Labs Inc. (OTCMKTS:CRLBF) – Analysts at Roth Capital issued their Q1 2025 earnings per share (EPS) estimates for Cresco Labs in a report released on Thursday, March 13th. Roth Capital analyst W. Kirk forecasts that the company will earn ($0.03) per share for the quarter. The consensus estimate for Cresco Labs’ current full-year earnings is ($0.20) per share. Roth Capital also issued estimates for Cresco Labs’ Q2 2025 earnings at ($0.02) EPS, Q3 2025 earnings at ($0.02) EPS, Q4 2025 earnings at ($0.01) EPS, FY2025 earnings at ($0.08) EPS and FY2026 earnings at ($0.04) EPS.

Cresco Labs (OTCMKTS:CRLBF) last posted its earnings results on Friday, March 14th. The company reported ($0.01) earnings per share for the quarter, meeting the consensus estimate of ($0.01). The company had revenue of $176.00 million for the quarter, compared to analyst estimates of $172.10 million. Cresco Labs had a negative return on equity of 16.52% and a negative net margin of 9.15%.

Separately, Atb Cap Markets lowered Cresco Labs from a “strong-buy” rating to a “hold” rating in a research note on Monday, December 9th. Three investment analysts have rated the stock with a hold rating, one has issued a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $3.00.

Cresco Labs Stock Down 0.8 %

Cresco Labs stock opened at $0.73 on Monday. The company has a debt-to-equity ratio of 1.80, a quick ratio of 1.39 and a current ratio of 1.97. The firm has a market capitalization of $358.29 million, a price-to-earnings ratio of -3.67 and a beta of 1.79. Cresco Labs has a fifty-two week low of $0.70 and a fifty-two week high of $2.60. The stock’s fifty day moving average is $0.88 and its two-hundred day moving average is $1.19.

Cresco Labs Company Profile

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.